Guideline Recommendations and Evidence for Metoprolol Succinate Extended‑Release in Heart Failure

Guideline‑Directed Dosing

• The ACC/AHA heart‑failure guidelines recommend initiating metoprolol succinate ER at 12.5–25 mg once daily and titrating to a target dose of 200 mg daily in patients with reduced ejection fraction【1】.

Clinical Trial Evidence

• The MERIT‑HF randomized controlled trial showed a 34 % relative reduction in all‑cause mortality with metoprolol CR/XL 200 mg once daily (mean achieved dose ≈ 159 mg/day) in patients with systolic heart failure【4】 (Level A evidence).

Formulation Equivalence and Dosing Considerations

• Although metoprolol succinate (extended‑release) and metoprolol tartrate (immediate‑release) have approximately equivalent milligram strengths, they are not interchangeable without adjusting dosing frequency; succinate is taken once daily, whereas tartrate requires twice‑daily or more frequent dosing【1】.